---
schema_version: "secwatch.filing_event.v1"
accession: "0001808805-23-000066"
form_type: "8-K"
ticker: "NAUT"
cik: "0001808805"
company_name: "Nautilus Biotechnology, Inc."
filed_at: "2023-08-02T23:59:59+00:00"
generated_at: "2026-06-12T14:32:32.159931+00:00"
event_type: "earnings"
sentiment: "neutral"
materiality_score: 0.5
calibrated_materiality_score: 0.5
confidence: "high"
source: SEC EDGAR
---

# Nautilus Q2 net loss $15.8M; cash runway extended through 2025-2026

## Summary
- Operating expenses $19.0M, up 23% YoY from $15.5M driven by product development headcount.
- Net loss $15.8M vs $14.7M in Q2 2022; company pre-revenue, still in development stage.
- Cash, equivalents, and investments $286.7M as of June 30, 2023; CEO says funds operations into 2026.
- CEO reports progress integrating sample prep, probes, chips, instrument, and software for commercial launch.

## SEC filing metadata
- accession: 0001808805-23-000066
- form_type: 8-K
- ticker: NAUT
- cik: 0001808805
- company_name: Nautilus Biotechnology, Inc.
- filed_at: 2023-08-02T23:59:59+00:00
- event_type: earnings
- sentiment: neutral
- materiality_score: 0.5
- calibrated_materiality_score: 0.5
- confidence: high
- sec_items: 2.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1808805/000180880523000066/0001808805-23-000066-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1808805/000180880523000066/naut-20230802.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001808805-23-000066
- JSON: https://secwatch.observer/filing/0001808805-23-000066.json
- Plain text: https://secwatch.observer/filing/0001808805-23-000066.txt

## Key facts
- Earnings Releases
  Nautilus Biotechnology, Inc. reported second quarter ended June 30, 2023 results: net income $15.8 million.
  - Period: second quarter ended June 30, 2023
  - Net income: $15.8 million
  - Result: reported results
  source text: Net loss was $15.8 million for the second quarter of 2023
  evidence_url: https://www.sec.gov/Archives/edgar/data/1808805/000180880523000066/0001808805-23-000066-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.